466 related articles for article (PubMed ID: 18501769)
1. HLA class II transgenic mice mimic human inflammatory diseases.
Mangalam AK; Rajagopalan G; Taneja V; David CS
Adv Immunol; 2008; 97():65-147. PubMed ID: 18501769
[TBL] [Abstract][Full Text] [Related]
2. HLA transgenic mice as models of human autoimmune diseases.
Das P; Abraham R; David C
Rev Immunogenet; 2000; 2(1):105-14. PubMed ID: 11324683
[TBL] [Abstract][Full Text] [Related]
3. Humanized animal models for autoimmune diseases.
Gregersen JW; Holmes S; Fugger L
Tissue Antigens; 2004 May; 63(5):383-94. PubMed ID: 15104670
[TBL] [Abstract][Full Text] [Related]
4. Role of MHC class II expressing CD4+ T cells in proteolipid protein(91-110)-induced EAE in HLA-DR3 transgenic mice.
Mangalam A; Rodriguez M; David C
Eur J Immunol; 2006 Dec; 36(12):3356-70. PubMed ID: 17125142
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
[TBL] [Abstract][Full Text] [Related]
6. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
[TBL] [Abstract][Full Text] [Related]
7. HLA transgenic mice as humanized mouse models of disease and immunity.
Taneja V; David CS
J Clin Invest; 1998 Mar; 101(5):921-6. PubMed ID: 9486959
[No Abstract] [Full Text] [Related]
8. Characterization of HLA DR3/DQ2 transgenic mice: a potential humanized animal model for autoimmune disease studies.
Chen D; Ueda R; Harding F; Patil N; Mao Y; Kurahara C; Platenburg G; Huang M
Eur J Immunol; 2003 Jan; 33(1):172-82. PubMed ID: 12594846
[TBL] [Abstract][Full Text] [Related]
9. Humanized transgenic mice expressing HLA DR4-DQ3 haplotype: reconstitution of phenotype and HLA-restricted T-cell responses.
Chen Z; de Kauwe AL; Keech C; Wijburg O; Simpfendorfer K; Alexander WS; McCluskey J
Tissue Antigens; 2006 Sep; 68(3):210-9. PubMed ID: 16948641
[TBL] [Abstract][Full Text] [Related]
10. HLA-DQ6/8 double transgenic mice develop auricular chondritis following type II collagen immunization: a model for human relapsing polychondritis.
Bradley DS; Das P; Griffiths MM; Luthra HS; David CS
J Immunol; 1998 Nov; 161(9):5046-53. PubMed ID: 9794442
[TBL] [Abstract][Full Text] [Related]
11. Identification of T cell epitopes on human proteolipid protein and induction of experimental autoimmune encephalomyelitis in HLA class II-transgenic mice.
Mangalam AK; Khare M; Krco C; Rodriguez M; David C
Eur J Immunol; 2004 Jan; 34(1):280-90. PubMed ID: 14971054
[TBL] [Abstract][Full Text] [Related]
12. Induction of arthritis in HLA-DR4-humanized and HLA-DQ8-humanized mice by human cartilage proteoglycan aggrecan but only in the presence of an appropriate (non-MHC) genetic background.
Szántó S; Bárdos T; Szabó Z; David CS; Buzás EI; Mikecz K; Glant TT
Arthritis Rheum; 2004 Jun; 50(6):1984-95. PubMed ID: 15188376
[TBL] [Abstract][Full Text] [Related]
13. HLA class II polymorphism: implications for genetic susceptibility to autoimmune disease.
Gregersen PK
Lab Invest; 1989 Jul; 61(1):5-19. PubMed ID: 2664347
[TBL] [Abstract][Full Text] [Related]
14. [Binding-peptide motifs of HLA class II molecules susceptible to autoimmune diseases].
Nishimura Y
Nihon Rinsho; 1997 Jun; 55(6):1384-96. PubMed ID: 9200922
[TBL] [Abstract][Full Text] [Related]
15. HLA DR and DQ interaction in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in HLA class II transgenic mice.
Khare M; Mangalam A; Rodriguez M; David CS
J Neuroimmunol; 2005 Dec; 169(1-2):1-12. PubMed ID: 16194572
[TBL] [Abstract][Full Text] [Related]
16. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells.
de Kauwe AL; Chen Z; Anderson RP; Keech CL; Price JD; Wijburg O; Jackson DC; Ladhams J; Allison J; McCluskey J
J Immunol; 2009 Jun; 182(12):7440-50. PubMed ID: 19494267
[TBL] [Abstract][Full Text] [Related]
17. HLA class II transgenic mice as models of human diseases.
Taneja V; David CS
Immunol Rev; 1999 Jun; 169():67-79. PubMed ID: 10450509
[TBL] [Abstract][Full Text] [Related]
18. Exploring the reciprocal relationship between immunity and inflammation in chronic inflammatory arthritis.
Cope AP
Rheumatology (Oxford); 2003 Jun; 42(6):716-31. PubMed ID: 12730506
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism at the HLA-DQ locus determines susceptibility to experimental autoimmune myasthenia gravis.
Raju R; Zhan WZ; Karachunski P; Conti-Fine B; Sieck GC; David C
J Immunol; 1998 May; 160(9):4169-74. PubMed ID: 9574516
[TBL] [Abstract][Full Text] [Related]
20. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus.
Todd JA; Bell JI; McDevitt HO
Nature; 1987 Oct 15-21; 329(6140):599-604. PubMed ID: 3309680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
